Cheryl R Blanchard - President, Anika Therapeutics, Inc

As of April 28, 2022


What is Cheryl R Blanchard's Net Worth?

The current estimated net worth of Anika Therapeutics, Inc's President, Cheryl R Blanchard, is estimated to be about $3.19M . Cheryl R Blanchard owns about 59,992 units of Anika Therapeutics, Inc common stock. In the last 4 years at Anika Therapeutics, Inc, Cheryl R Blanchard has sold an estimated value of $59.92K worth.

What is Cheryl R Blanchard's Past Insider Trading?

Cheryl R Blanchard's largest purchase order was 8,100 units , worth over $207.14K on March 14, 2022. In total, Cheryl R Blanchard has made about 11 transactions over 4 years of their time at Anika Therapeutics, Inc. Cheryl R Blanchard usually trades in March, with the busiest year in 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Cheryl R Blanchard's Salary in 2020?

As President of Anika Therapeutics, Inc, Cheryl R Blanchard has a total base salary of $548,077 . Cheryl R Blanchard received compensation valued at about $10,029,434 in 2020 after becoming President. The vast majority of their compensation came in the form of a bonus of $458,510 , other earnings, plans or compensations of $5,335,439 , option awards of $3,659,450 , and other compensation of $27,958 .

What is Cheryl R Blanchard's' Mailing Address?

  • Mailing address is C/o Zimmer, Inc. P.O. Box 708 Warsaw IN 46580 IN

Anika Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Other Earnings Plans or Compensations
Option Awards
Other Compensation
Total
Cheryl R. Blanchard, Ph.D. 2020 $548,077 $458,510 $5,335,439 $3,659,450 $27,958 $10,029,434
Michael L. Levitz 2020 $173,077 $73,601 $799,971 $799,993 $11,318 $1,857,960
David Colleran 2020 $344,077 $143,931 $645,900 $553,445 $18,263 $1,705,616
Thomas Finnerty 2020 $353,505 $143,169 $626,367 - $20,746 $1,143,787
James Loerop 2020 $381,563 $171,703 $464,449 - $22,156 $1,039,871
Joseph G. Darling 2020 $80,752 - - - $208,001 $288,753
Sylvia Cheung 2020 $294,252 - $924,637 - $89,644 $1,308,534
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/898437/000117184321002976/def14a_042921.htm

What are Anika Therapeutics, Inc's Past Insider Trades?

Anika Therapeutics, Inc's most recent insider trade came on May 12, 2022 by David Colleran who bought 1,500 units worth $32.05K . In the last 18 years, insiders at Anika Therapeutics, Inc have sold an estimated value of $66.56M and bought an estimated value of $5.82M worth of shares. Insider trading is most common in February, with the busiest year in 2017 and 2006. The most active traders at the company are Charles H Sherwood, CEO and Director,  Steve Wheeler, Director,  and Joseph L Bower, Director .

Anika Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1